nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—nephron tubule—kidney cancer	0.00778	0.19	CbGeAlD
Gadopentetate dimeglumine—PGD—renal system—kidney cancer	0.00707	0.172	CbGeAlD
Gadopentetate dimeglumine—PGD—kidney—kidney cancer	0.00684	0.167	CbGeAlD
Gadopentetate dimeglumine—PGD—cortex of kidney—kidney cancer	0.00666	0.162	CbGeAlD
Gadopentetate dimeglumine—PGD—gonad—kidney cancer	0.00634	0.155	CbGeAlD
Gadopentetate dimeglumine—PGD—cardiac atrium—kidney cancer	0.00634	0.154	CbGeAlD
Gadopentetate dimeglumine—Malaise—Paclitaxel—kidney cancer	0.000555	0.00058	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Paclitaxel—kidney cancer	0.000552	0.000576	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Sunitinib—kidney cancer	0.000551	0.000575	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Vincristine—kidney cancer	0.00055	0.000574	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Sorafenib—kidney cancer	0.00055	0.000574	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Erlotinib—kidney cancer	0.000549	0.000574	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Capecitabine—kidney cancer	0.000548	0.000573	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000546	0.000571	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000546	0.00057	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Vincristine—kidney cancer	0.000545	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Rash—Erlotinib—kidney cancer	0.000544	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Erlotinib—kidney cancer	0.000544	0.000568	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Capecitabine—kidney cancer	0.000542	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Headache—Erlotinib—kidney cancer	0.000541	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Capecitabine—kidney cancer	0.000541	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Paclitaxel—kidney cancer	0.000541	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Pain—Vincristine—kidney cancer	0.000541	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Vincristine—kidney cancer	0.000541	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Doxorubicin—kidney cancer	0.00054	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Doxorubicin—kidney cancer	0.00054	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Gemcitabine—kidney cancer	0.000538	0.000563	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Capecitabine—kidney cancer	0.000538	0.000562	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Capecitabine—kidney cancer	0.000538	0.000562	CcSEcCtD
Gadopentetate dimeglumine—Cough—Paclitaxel—kidney cancer	0.000537	0.000561	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Sunitinib—kidney cancer	0.000536	0.00056	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Gemcitabine—kidney cancer	0.000535	0.000559	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vinblastine—kidney cancer	0.000534	0.000557	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Gemcitabine—kidney cancer	0.000533	0.000557	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Paclitaxel—kidney cancer	0.000533	0.000557	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Doxorubicin—kidney cancer	0.000532	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Everolimus—kidney cancer	0.000531	0.000555	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Sorafenib—kidney cancer	0.000531	0.000555	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Paclitaxel—kidney cancer	0.000531	0.000555	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Sunitinib—kidney cancer	0.000529	0.000552	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Capecitabine—kidney cancer	0.000526	0.00055	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Capecitabine—kidney cancer	0.000524	0.000547	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Paclitaxel—kidney cancer	0.000524	0.000547	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Paclitaxel—kidney cancer	0.000524	0.000547	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Capecitabine—kidney cancer	0.000523	0.000546	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Paclitaxel—kidney cancer	0.000522	0.000545	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Doxorubicin—kidney cancer	0.000522	0.000545	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Gemcitabine—kidney cancer	0.000521	0.000545	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Dactinomycin—kidney cancer	0.000521	0.000545	CcSEcCtD
Gadopentetate dimeglumine—Chills—Capecitabine—kidney cancer	0.00052	0.000544	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00052	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Capecitabine—kidney cancer	0.000518	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000518	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Gemcitabine—kidney cancer	0.000517	0.00054	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Vincristine—kidney cancer	0.000517	0.00054	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Doxorubicin—kidney cancer	0.000514	0.000537	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Sorafenib—kidney cancer	0.000514	0.000537	CcSEcCtD
Gadopentetate dimeglumine—Pain—Gemcitabine—kidney cancer	0.000513	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Gemcitabine—kidney cancer	0.000513	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Erlotinib—kidney cancer	0.000513	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Paclitaxel—kidney cancer	0.000512	0.000535	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Sunitinib—kidney cancer	0.000511	0.000534	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Capecitabine—kidney cancer	0.000508	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Dactinomycin—kidney cancer	0.000508	0.00053	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Paclitaxel—kidney cancer	0.000506	0.000529	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Doxorubicin—kidney cancer	0.000506	0.000529	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Capecitabine—kidney cancer	0.000505	0.000528	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000502	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Vincristine—kidney cancer	0.0005	0.000522	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Vincristine—kidney cancer	0.0005	0.000522	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Capecitabine—kidney cancer	0.000494	0.000517	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Sunitinib—kidney cancer	0.000494	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Gemcitabine—kidney cancer	0.000494	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Shock—Paclitaxel—kidney cancer	0.000494	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Sorafenib—kidney cancer	0.000494	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000494	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Paclitaxel—kidney cancer	0.000492	0.000514	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Paclitaxel—kidney cancer	0.00049	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Rash—Sorafenib—kidney cancer	0.00049	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Sorafenib—kidney cancer	0.000489	0.000511	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Capecitabine—kidney cancer	0.000488	0.00051	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Paclitaxel—kidney cancer	0.000488	0.00051	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000487	0.000508	CcSEcCtD
Gadopentetate dimeglumine—Headache—Sorafenib—kidney cancer	0.000487	0.000508	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000485	0.000507	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Dactinomycin—kidney cancer	0.000484	0.000506	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000483	0.000505	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Paclitaxel—kidney cancer	0.000479	0.0005	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Sunitinib—kidney cancer	0.000475	0.000497	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Gemcitabine—kidney cancer	0.000474	0.000495	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Capecitabine—kidney cancer	0.000473	0.000494	CcSEcCtD
Gadopentetate dimeglumine—Rash—Sunitinib—kidney cancer	0.000471	0.000492	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Sunitinib—kidney cancer	0.000471	0.000492	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Paclitaxel—kidney cancer	0.000469	0.00049	CcSEcCtD
Gadopentetate dimeglumine—Headache—Sunitinib—kidney cancer	0.000468	0.000489	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Vincristine—kidney cancer	0.000466	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Sorafenib—kidney cancer	0.000461	0.000482	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000457	0.000478	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Capecitabine—kidney cancer	0.000455	0.000476	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Doxorubicin—kidney cancer	0.000455	0.000475	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Vincristine—kidney cancer	0.000454	0.000474	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Capecitabine—kidney cancer	0.000453	0.000473	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Paclitaxel—kidney cancer	0.000451	0.000471	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Dactinomycin—kidney cancer	0.00045	0.00047	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Paclitaxel—kidney cancer	0.000448	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Paclitaxel—kidney cancer	0.000446	0.000466	CcSEcCtD
Gadopentetate dimeglumine—Rash—Dactinomycin—kidney cancer	0.000446	0.000466	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Sunitinib—kidney cancer	0.000444	0.000464	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Capecitabine—kidney cancer	0.000444	0.000464	CcSEcCtD
Gadopentetate dimeglumine—Cough—Capecitabine—kidney cancer	0.000441	0.00046	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Paclitaxel—kidney cancer	0.000436	0.000456	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Capecitabine—kidney cancer	0.000436	0.000455	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000433	0.000453	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Paclitaxel—kidney cancer	0.000433	0.000452	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Vincristine—kidney cancer	0.000433	0.000452	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Doxorubicin—kidney cancer	0.000431	0.000451	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Gemcitabine—kidney cancer	0.00043	0.00045	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Capecitabine—kidney cancer	0.00043	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Capecitabine—kidney cancer	0.00043	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Pain—Paclitaxel—kidney cancer	0.000429	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Paclitaxel—kidney cancer	0.000429	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Capecitabine—kidney cancer	0.000428	0.000448	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000427	0.000446	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Gemcitabine—kidney cancer	0.000424	0.000443	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Capecitabine—kidney cancer	0.00042	0.000439	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Dactinomycin—kidney cancer	0.00042	0.000439	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Vincristine—kidney cancer	0.000418	0.000437	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Doxorubicin—kidney cancer	0.000416	0.000435	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Capecitabine—kidney cancer	0.000415	0.000434	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Paclitaxel—kidney cancer	0.000414	0.000432	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000411	0.000429	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Gemcitabine—kidney cancer	0.00041	0.000429	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Doxorubicin—kidney cancer	0.000409	0.000428	CcSEcCtD
Gadopentetate dimeglumine—Shock—Capecitabine—kidney cancer	0.000405	0.000424	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—kidney cancer	0.000405	0.000423	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Capecitabine—kidney cancer	0.000404	0.000422	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Capecitabine—kidney cancer	0.000402	0.00042	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Vincristine—kidney cancer	0.000402	0.00042	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Capecitabine—kidney cancer	0.0004	0.000418	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—kidney cancer	0.000399	0.000417	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Paclitaxel—kidney cancer	0.000399	0.000417	CcSEcCtD
Gadopentetate dimeglumine—Rash—Vincristine—kidney cancer	0.000399	0.000416	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Capecitabine—kidney cancer	0.000398	0.000416	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Vincristine—kidney cancer	0.000398	0.000416	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Paclitaxel—kidney cancer	0.000397	0.000415	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Paclitaxel—kidney cancer	0.000397	0.000415	CcSEcCtD
Gadopentetate dimeglumine—Headache—Vincristine—kidney cancer	0.000396	0.000414	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000394	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Capecitabine—kidney cancer	0.000393	0.00041	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Capecitabine—kidney cancer	0.000385	0.000402	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Gemcitabine—kidney cancer	0.000381	0.000398	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—kidney cancer	0.000381	0.000398	CcSEcCtD
Gadopentetate dimeglumine—Rash—Gemcitabine—kidney cancer	0.000378	0.000395	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Gemcitabine—kidney cancer	0.000378	0.000395	CcSEcCtD
Gadopentetate dimeglumine—Headache—Gemcitabine—kidney cancer	0.000376	0.000393	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vincristine—kidney cancer	0.000375	0.000392	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000375	0.000392	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—kidney cancer	0.000375	0.000392	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Capecitabine—kidney cancer	0.00037	0.000387	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Paclitaxel—kidney cancer	0.00037	0.000387	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—kidney cancer	0.000369	0.000386	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—kidney cancer	0.000368	0.000385	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—kidney cancer	0.000367	0.000384	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Capecitabine—kidney cancer	0.000367	0.000384	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—kidney cancer	0.000366	0.000383	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—kidney cancer	0.00036	0.000376	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Paclitaxel—kidney cancer	0.00036	0.000376	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Capecitabine—kidney cancer	0.000358	0.000374	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Gemcitabine—kidney cancer	0.000356	0.000372	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000356	0.000372	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Capecitabine—kidney cancer	0.000355	0.000371	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Paclitaxel—kidney cancer	0.000355	0.000371	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—kidney cancer	0.000353	0.000369	CcSEcCtD
Gadopentetate dimeglumine—Pain—Capecitabine—kidney cancer	0.000352	0.000368	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Capecitabine—kidney cancer	0.000352	0.000368	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—kidney cancer	0.000349	0.000365	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—kidney cancer	0.000349	0.000364	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—kidney cancer	0.000347	0.000363	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—kidney cancer	0.000347	0.000363	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Paclitaxel—kidney cancer	0.000344	0.000359	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Capecitabine—kidney cancer	0.00034	0.000355	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—kidney cancer	0.000339	0.000354	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—kidney cancer	0.000338	0.000353	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000337	0.000352	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000337	0.000352	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—kidney cancer	0.000335	0.00035	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—kidney cancer	0.000334	0.000349	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Paclitaxel—kidney cancer	0.000332	0.000347	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—kidney cancer	0.000328	0.000342	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Capecitabine—kidney cancer	0.000327	0.000342	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Capecitabine—kidney cancer	0.000326	0.00034	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Capecitabine—kidney cancer	0.000326	0.00034	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—kidney cancer	0.000325	0.00034	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—kidney cancer	0.000319	0.000334	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Paclitaxel—kidney cancer	0.000319	0.000334	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—kidney cancer	0.000319	0.000333	CcSEcCtD
Gadopentetate dimeglumine—Rash—Paclitaxel—kidney cancer	0.000317	0.000331	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Paclitaxel—kidney cancer	0.000316	0.00033	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—kidney cancer	0.000315	0.000329	CcSEcCtD
Gadopentetate dimeglumine—Headache—Paclitaxel—kidney cancer	0.000315	0.000329	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Capecitabine—kidney cancer	0.000304	0.000317	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—kidney cancer	0.000299	0.000312	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Paclitaxel—kidney cancer	0.000298	0.000312	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Capecitabine—kidney cancer	0.000296	0.000309	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—kidney cancer	0.000293	0.000307	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—kidney cancer	0.000292	0.000305	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Capecitabine—kidney cancer	0.000292	0.000305	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—kidney cancer	0.000286	0.000299	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—kidney cancer	0.000284	0.000297	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—kidney cancer	0.000282	0.000295	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Capecitabine—kidney cancer	0.000282	0.000295	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—kidney cancer	0.000281	0.000294	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—kidney cancer	0.000277	0.000289	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—kidney cancer	0.000277	0.000289	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—kidney cancer	0.000276	0.000288	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000275	0.000287	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Capecitabine—kidney cancer	0.000272	0.000285	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—kidney cancer	0.000271	0.000283	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—kidney cancer	0.000268	0.00028	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000266	0.000278	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Capecitabine—kidney cancer	0.000262	0.000274	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—kidney cancer	0.000261	0.000273	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—kidney cancer	0.00026	0.000272	CcSEcCtD
Gadopentetate dimeglumine—Rash—Capecitabine—kidney cancer	0.00026	0.000271	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Capecitabine—kidney cancer	0.00026	0.000271	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—kidney cancer	0.000259	0.000271	CcSEcCtD
Gadopentetate dimeglumine—Headache—Capecitabine—kidney cancer	0.000258	0.00027	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—kidney cancer	0.000258	0.00027	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000257	0.000268	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—kidney cancer	0.000253	0.000265	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—kidney cancer	0.000248	0.000259	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Capecitabine—kidney cancer	0.000245	0.000256	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000242	0.000253	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—kidney cancer	0.000238	0.000249	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—kidney cancer	0.000237	0.000247	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—kidney cancer	0.000236	0.000247	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—kidney cancer	0.000231	0.000241	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000229	0.00024	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—kidney cancer	0.000229	0.000239	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—kidney cancer	0.000227	0.000237	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—kidney cancer	0.000227	0.000237	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—kidney cancer	0.000219	0.000229	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000217	0.000227	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—kidney cancer	0.000211	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—kidney cancer	0.00021	0.000219	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—kidney cancer	0.00021	0.000219	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—kidney cancer	0.000196	0.000204	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—kidney cancer	0.000191	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—kidney cancer	0.000188	0.000196	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—kidney cancer	0.000182	0.00019	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—kidney cancer	0.000176	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—kidney cancer	0.000169	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—kidney cancer	0.000167	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—kidney cancer	0.000167	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—kidney cancer	0.000166	0.000174	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Doxorubicin—kidney cancer	0.000158	0.000165	CcSEcCtD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC5A3—kidney cancer	0.00013	0.0684	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—KEAP1—kidney cancer	0.000114	0.0597	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—GPC3—kidney cancer	9.51e-05	0.0498	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ST3GAL2—kidney cancer	8.8e-05	0.0461	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PGK1—kidney cancer	8.25e-05	0.0432	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC5A3—kidney cancer	8.25e-05	0.0432	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC5A5—kidney cancer	6.88e-05	0.0361	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A1—kidney cancer	6.65e-05	0.0348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—EGR1—kidney cancer	6.17e-05	0.0323	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTP1—kidney cancer	5.54e-05	0.029	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTM1—kidney cancer	5.09e-05	0.0267	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A1—kidney cancer	4.2e-05	0.022	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACY1—kidney cancer	3.73e-05	0.0195	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CCBL1—kidney cancer	3.56e-05	0.0186	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AMER1—kidney cancer	3.22e-05	0.0168	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PDHB—kidney cancer	3.17e-05	0.0166	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CCBL1—kidney cancer	2.98e-05	0.0156	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GPC3—kidney cancer	2.7e-05	0.0141	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GLIPR1—kidney cancer	2.58e-05	0.0135	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPAT—kidney cancer	2.58e-05	0.0135	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ST3GAL2—kidney cancer	2.49e-05	0.0131	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—APRT—kidney cancer	2.4e-05	0.0126	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FH—kidney cancer	2.4e-05	0.0126	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SLC5A3—kidney cancer	2.34e-05	0.0122	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PGK1—kidney cancer	2.34e-05	0.0122	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SFRP2—kidney cancer	2.29e-05	0.012	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LDHB—kidney cancer	2.29e-05	0.012	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPC3—kidney cancer	2.26e-05	0.0118	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA2—kidney cancer	2.2e-05	0.0115	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALAD—kidney cancer	2.14e-05	0.0112	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TCEB2—kidney cancer	2.14e-05	0.0112	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TCEB1—kidney cancer	2.14e-05	0.0112	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ST3GAL2—kidney cancer	2.09e-05	0.0109	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALDH1A1—kidney cancer	2.04e-05	0.0107	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC5A3—kidney cancer	1.96e-05	0.0103	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PGK1—kidney cancer	1.96e-05	0.0103	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LDHB—kidney cancer	1.92e-05	0.0101	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL14—kidney cancer	1.74e-05	0.0091	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA9—kidney cancer	1.66e-05	0.00872	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ITPR2—kidney cancer	1.57e-05	0.00823	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CRABP1—kidney cancer	1.42e-05	0.00741	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PSMD7—kidney cancer	1.32e-05	0.0069	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ITPR2—kidney cancer	1.32e-05	0.00689	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACHE—kidney cancer	1.2e-05	0.00628	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTT1—kidney cancer	1.2e-05	0.00628	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SLC2A1—kidney cancer	1.19e-05	0.00624	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—JUNB—kidney cancer	1.18e-05	0.00619	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SCARB1—kidney cancer	1.14e-05	0.00595	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS1—kidney cancer	1.12e-05	0.00589	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PSMD7—kidney cancer	1.1e-05	0.00578	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—BCHE—kidney cancer	1.05e-05	0.00547	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC5A5—kidney cancer	1.03e-05	0.00541	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A1—kidney cancer	9.97e-06	0.00522	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CDKN2B—kidney cancer	9.62e-06	0.00504	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTP1—kidney cancer	8.32e-06	0.00436	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ABCB1—kidney cancer	7.87e-06	0.00412	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIF1A—kidney cancer	7.69e-06	0.00403	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TSC2—kidney cancer	7.67e-06	0.00402	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTM1—kidney cancer	7.64e-06	0.004	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP1A1—kidney cancer	7.24e-06	0.00379	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—APC—kidney cancer	6.78e-06	0.00355	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—KIT—kidney cancer	6.78e-06	0.00355	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—BRAF—kidney cancer	6.37e-06	0.00334	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—POMC—kidney cancer	5.4e-06	0.00283	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RAF1—kidney cancer	5.32e-06	0.00279	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERBB2—kidney cancer	5.26e-06	0.00276	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MTOR—kidney cancer	5.19e-06	0.00272	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CD4—kidney cancer	5.18e-06	0.00271	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTGS2—kidney cancer	5.14e-06	0.00269	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CDKN1B—kidney cancer	4.87e-06	0.00255	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CTNNB1—kidney cancer	4.6e-06	0.00241	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTEN—kidney cancer	4.49e-06	0.00235	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS2—kidney cancer	4.31e-06	0.00226	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAPK3—kidney cancer	3.83e-06	0.00201	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTEN—kidney cancer	3.76e-06	0.00197	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MYC—kidney cancer	3.73e-06	0.00195	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAPK1—kidney cancer	3.65e-06	0.00191	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—KRAS—kidney cancer	3.45e-06	0.0018	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PIK3CA—kidney cancer	3.17e-06	0.00166	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CA—kidney cancer	2.65e-06	0.00139	CbGpPWpGaD
